Table 2.
Test/Reportgroup | Antimicrobialagent | DiskContent (µg) | Zone Diameter Breakpoints, Nearest Whole mm | MIC Interpretive Standard (µg/mL) | ||||
---|---|---|---|---|---|---|---|---|
S | I | R | S | I | R | |||
A | Ampicillin | 10 | ≥17 | 14–16 | ≤13 | ≤6 | 16 | ≥32 |
A | Gentamycin | 10 | ≥15 | 13–14 | ≤12 | ≤4 | 8 | ≥16 |
B | Amikacin | 30 | ≥17 | 15–16 | ≤14 | ≤16 | 32 | ≥64 |
O | Streptomycin | 10 | ≥15 | 12–14 | ≤11 | - | - | - |
O | Kanamycin | 30 | ≥18 | 14–17 | ≤13 | ≤16 | 32 | ≥64 |
C | Tetracycline | 30 | ≥15 | 12–14 | ≤11 | ≤4 | 8 | ≥16 |
B | Ciproflaxacin | 5 | ≥21 | 16–20 | ≤15 | ≤1 | 2 | ≥4 |
U | Norflaxacin | 10 | ≥17 | 13–16 | ≤12 | ≤4 | 8 | ≥16 |
B | Trimethoprime-sulfamethoxazole | 1.25/23.75 | ≥16 | 11–15 | ≤10 | ≤2/38 | - | ≥4/76 |
C | Chloramfenicol | 30 | ≥18 | 13–17 | ≤12 | ≤8 | 16 | ≥32 |